T-cell exhaustion and elevated fibronectin type III domain-containing protein 4 (FNDC4) expression are independently associated with poor prognosis in lung cancer (Liu et al., 2024; Xu and Lu, 2024). This evidence concerns the gene FNDC4 and lung carcinoma.